These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27011226)

  • 1. Retinoic Acid for High-risk Neuroblastoma Patients after Autologous Stem Cell Transplantation - Cochrane Review.
    Peinemann F; van Dalen EC; Berthold F
    Klin Padiatr; 2016 Apr; 228(3):124-9. PubMed ID: 27011226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation.
    Peinemann F; van Dalen EC; Tushabe DA; Berthold F
    Cochrane Database Syst Rev; 2015 Jan; 1():CD010685. PubMed ID: 25634649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation.
    Peinemann F; van Dalen EC; Enk H; Berthold F
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010685. PubMed ID: 28840597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid COJEC Induction Therapy for High-risk Neuroblastoma Patients - Cochrane Review.
    Peinemann F; van Dalen EC; Berthold F
    Klin Padiatr; 2016 Apr; 228(3):130-4. PubMed ID: 27043079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.
    Matthay KK; Villablanca JG; Seeger RC; Stram DO; Harris RE; Ramsay NK; Swift P; Shimada H; Black CT; Brodeur GM; Gerbing RB; Reynolds CP
    N Engl J Med; 1999 Oct; 341(16):1165-73. PubMed ID: 10519894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
    Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
    J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.
    Park JR; Villablanca JG; London WB; Gerbing RB; Haas-Kogan D; Adkins ES; Attiyeh EF; Maris JM; Seeger RC; Reynolds CP; Matthay KK;
    Pediatr Blood Cancer; 2009 Jan; 52(1):44-50. PubMed ID: 18937318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study.
    Seeger RC; Reynolds CP; Gallego R; Stram DO; Gerbing RB; Matthay KK
    J Clin Oncol; 2000 Dec; 18(24):4067-76. PubMed ID: 11118468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
    Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
    Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.
    Stram DO; Matthay KK; O'Leary M; Reynolds CP; Haase GM; Atkinson JB; Brodeur GM; Seeger RC
    J Clin Oncol; 1996 Sep; 14(9):2417-26. PubMed ID: 8823319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of high-risk neuroblastoma with intensive chemotherapy, autologous peripheral blood stem cell transplantation, and 13-cis-retinoic acid].
    Tang SQ; Huang DS; Wang JW; Zhang XF; Liu LZ; Yu F; Yang G
    Zhonghua Er Ke Za Zhi; 2004 Jul; 42(7):486-9. PubMed ID: 15324562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metastatic neuroblastoma: consolidation treatment with 2 courses of high-dose chemotherapy followed by a bone marrow autograft].
    Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
    Bull Cancer; 1988; 75(1):119-23. PubMed ID: 3282574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.
    Matthay KK; Seeger RC; Reynolds CP; Stram DO; O'Leary MC; Harris RE; Selch M; Atkinson JB; Haase GM; Ramsay NK
    J Clin Oncol; 1994 Nov; 12(11):2382-9. PubMed ID: 7964954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin.
    Kushner BH; Ostrovnaya I; Cheung IY; Kuk D; Modak S; Kramer K; Roberts SS; Basu EM; Yataghene K; Cheung NK
    Oncotarget; 2016 Jan; 7(4):4155-66. PubMed ID: 26623730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma.
    Bradfield SM; Douglas JG; Hawkins DS; Sanders JE; Park JR
    Cancer; 2004 Mar; 100(6):1268-75. PubMed ID: 15022296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed surgery and bone marrow transplantation for widespread neuroblastoma.
    Moss TJ; Fonkalsrud EW; Feig SA; Lenarsky C; Selch M; Wells J; Seeger RC
    Ann Surg; 1987 Oct; 206(4):514-20. PubMed ID: 3310932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiotepa and melphalan based single, tandem, and triple high dose therapy and autologous stem cell transplantation for high risk neuroblastoma.
    Saarinen-Pihkala UM; Hovi L; Koivusalo A; Jahnukainen K; Karikoski R; Sariola H; Wikström S
    Pediatr Blood Cancer; 2012 Dec; 59(7):1190-7. PubMed ID: 22492714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term effect of high dose chemotherapy combined with stem cell transplantation on stage IV neuroblastoma in children].
    Tang SQ; Huang DS; Wang JW; Feng C; Yang G
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):93-6. PubMed ID: 16613697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma.
    Matthay KK
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S21-4. PubMed ID: 8971402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloablative therapy and bone marrow rescue in advanced neuroblastoma. Report from the Italian Bone Marrow Transplant Registry. Italian Association of Pediatric Hematology-Oncology, BMT Group.
    Garaventa A; Rondelli R; Lanino E; Dallorso S; Dini G; Bonetti F; Arrighini A; Santoro N; Rossetti F; Miniero R; Andolina M; Amici A; Indolfi P; Lo Curto M; Favre C; Paolucci P; Pession A; De Bernardi B
    Bone Marrow Transplant; 1996 Jul; 18(1):125-30. PubMed ID: 8832005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.